Who is sponsoring NCT04273659?

NCT04273659 is sponsored by University of Turku.

What drugs are being tested in NCT04273659?

Interventions in NCT04273659: Pulses and cereals.

Is NCT04273659 still recruiting?

NCT04273659 is currently completed. Last updated 5 October 2021.

Last reviewed 2021-10-05 · How we verify

NCT04273659

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Combining Cereals With Pulses - Reduced Gastrointestinal Symptoms?

Completed NA Last updated 5 October 2021

What this trial tests

NA trial testing Pulses and cereals in Unidentified Gastrointestinal Symptoms Following Pulses Consumption in 25 participants. Completed in 30 August 2021.

Timeline

12 February 2020

Primary endpoint
30 August 2021

30 August 2021

Quick facts

Lead sponsor	University of Turku
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	quadruple
Primary purpose	basic science
Enrollment	25
Start date	12 February 2020
Primary completion	30 August 2021
Estimated completion	30 August 2021
Sites	1 location across Finland

Drugs / interventions tested

Pulses and cereals

Conditions studied

Unidentified Gastrointestinal Symptoms Following Pulses Consumption — all drugs for Unidentified Gastrointestinal Symptoms Following Pulses Consumption →

Sponsor

University of Turku

Who can join

Adults 18 to 64, any sex, with Unidentified Gastrointestinal Symptoms Following Pulses Consumption. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of the study is to compare self-reported gastrointestinal symptoms and intestinal fermentation rates of the study products as measured by breath hydrogen and methane in adult population with self-reported mild abdominal sensitivity to pulses. The study products are a pulse products with two different cereals.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Effect of oat or rice flour on pulse-induced gastrointestinal symptoms and breath hydrogen in subjects sensitive to pulses and controls - a randomised cross-over trial with two parallel groups.
Laito S, Valkonen N, Laaksonen O, Kalliomäki M, et al · · 2022 · cited 4× · PMID 35086570 · DOI 10.1017/s0007114522000332

Verify or expand the search:

Other University of Turku trials

Trials by the same sponsor.

NCT07084389 — A Financial Social Work Intervention for Families With Complex Financial Difficulties (FinSoc) · NA · recruiting
NCT06886581 — Online Training Course to Improve Evidence-based Leadership · NA · recruiting
NCT06856408 — Power of Growth - Digitally Assisted Intervention for the Early Childhood Educators' Self-efficacy Teamwork and Children · NA · recruiting
NCT06627868 — Nicotinamide Adenine Dinucleotide (NAD+) Metabolism in Human Brown Adipose Tissue · NA · recruiting
NCT06284772 — FINRISK 2002 Re-examination · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04273659 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Turku
Last refreshed: 5 October 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04273659.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing